Oceana Biomedicina Journal
Vol 1, No 1 (2018): Oceana Biomedicina Journal

Recent Therapeutics Policies of Arthritis Rheumatoid (part I)

Andisari, Hendrata Erry ( Hang Tuah University )

Article Info

Publish Date
12 Jan 2018


Therapy in RA has undergone many advances today and in line with knowledge of the pathogenesis of RA, the current therapeutic goal is to alter the journey and control the activity of RA disease. Several groups of drugs have been used in RA therapy including non-steroidal anti-inflammatory drugs (NSAIDs), conventional disease-modifying antirheumatic drugs (DMARDs) as well as biological agents (bDMARD), glucocorticoids and anti-pain medicines. In recent years, the development of biological agents that have specific targets for inflammatory mediators such as interleukin (IL) -1, IL-6 and Tumor Necrosis Factor (TNF) suggests a potent therapeutic effect on RA. In this article will be presented the latest biological agents as the latest therapy on RA.

Copyrights © 2018

Journal Info





Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health


Hyperbaric medicine, marine medicine other than hyperbaric, on ships, boats and harbor health, maritime and coastal health, medicolegal aspects and medicolegal related to ships, ports and districts / maritime / coastal communities and fishermen, epidemiological aspects of diseases, disabilities and ...